Single-Dose Oral Fluconazole in the Treatment of Vaginal Candidosis

Early studies in patients demonstrated the potential of fluconazole, as a single oral 150-mg dose, for the treatment of vaginal candidosis. Fluconazole concentrations in plasma following this dose exceed the minimum inhibitory concentration (MIC) for most strains of Candida albicans (0.4-0.8 mg/l) f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the New York Academy of Sciences 1988, Vol.544 (1), p.561-563
Hauptverfasser: BRAMMER, KEITH W., FECZKO, JOSEPH M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 563
container_issue 1
container_start_page 561
container_title Annals of the New York Academy of Sciences
container_volume 544
creator BRAMMER, KEITH W.
FECZKO, JOSEPH M.
description Early studies in patients demonstrated the potential of fluconazole, as a single oral 150-mg dose, for the treatment of vaginal candidosis. Fluconazole concentrations in plasma following this dose exceed the minimum inhibitory concentration (MIC) for most strains of Candida albicans (0.4-0.8 mg/l) for 3-4 days. This paper presents the results of two multicenter clinical studies in which the efficacy of this fluconazole dosage was compared with 1) intravaginal clotrimazole (200 mg, in a standard local treatment for 3 consecutive days) and 2) oral ketoconazole (200 mg, twice a day for 5 consecutive days) in the treatment of patients with acute vaginal candidosis.
doi_str_mv 10.1111/j.1749-6632.1988.tb40452.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78620909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15727294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3541-cf2f2b1b89e85b2d3e67066572665564abceb2c8a71c71e8d24057a318a6f4623</originalsourceid><addsrcrecordid>eNqVkM1Kw0AURgdRtFYfQQgu3CXOTOYvbkSrVqG2YKviapgkNzo1TTSTYvXpTWjoVpzFncX33XPhIHRMcECadzoPiGSRL0RIAxIpFdQxw4zTYLWFeptoG_UwltJXEQ330L5zc4wJVUzuol2qOJZc9NBgaovXHPyr0oE3qUzu3eTLpCzMT5mDZwuvfgNvVoGpF1DUXpl5T-bVFk1vYIrUpqWz7gDtZCZ3cNj9ffR4cz0b3PqjyfBucDHyk5Az4icZzWhMYhWB4jFNQxASC8ElbQYXzMQJxDRRRpJEElApZZhLExJlRMYEDfvoZM39qMrPJbhaL6xLIM9NAeXSaakExRGO_iyS5qakEWuKZ-tiUpXOVZDpj8ouTPWtCdataj3XrU_d-tStat2p1qtm-ai7sowXkG5WO7dNfr7Ov2wO3_8g6_HLxZQL0hD8NcG6GlYbgqnetZCh5Pp5PNSXYkTvFX7QPPwFufCcLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15727294</pqid></control><display><type>article</type><title>Single-Dose Oral Fluconazole in the Treatment of Vaginal Candidosis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>BRAMMER, KEITH W. ; FECZKO, JOSEPH M.</creator><contributor>St. Georgiev, V</contributor><creatorcontrib>BRAMMER, KEITH W. ; FECZKO, JOSEPH M. ; St. Georgiev, V</creatorcontrib><description>Early studies in patients demonstrated the potential of fluconazole, as a single oral 150-mg dose, for the treatment of vaginal candidosis. Fluconazole concentrations in plasma following this dose exceed the minimum inhibitory concentration (MIC) for most strains of Candida albicans (0.4-0.8 mg/l) for 3-4 days. This paper presents the results of two multicenter clinical studies in which the efficacy of this fluconazole dosage was compared with 1) intravaginal clotrimazole (200 mg, in a standard local treatment for 3 consecutive days) and 2) oral ketoconazole (200 mg, twice a day for 5 consecutive days) in the treatment of patients with acute vaginal candidosis.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/j.1749-6632.1988.tb40452.x</identifier><identifier>PMID: 2850756</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Administration, Oral ; Administration, Topical ; Antifungal Agents - therapeutic use ; Candidiasis, Vulvovaginal - drug therapy ; Clinical Trials as Topic ; Double-Blind Method ; Drug Administration Schedule ; Female ; Fluconazole ; Humans ; Ketoconazole - therapeutic use ; Triazoles - administration &amp; dosage ; Triazoles - therapeutic use</subject><ispartof>Annals of the New York Academy of Sciences, 1988, Vol.544 (1), p.561-563</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3541-cf2f2b1b89e85b2d3e67066572665564abceb2c8a71c71e8d24057a318a6f4623</citedby><cites>FETCH-LOGICAL-c3541-cf2f2b1b89e85b2d3e67066572665564abceb2c8a71c71e8d24057a318a6f4623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1749-6632.1988.tb40452.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1749-6632.1988.tb40452.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,1411,4010,4036,4037,23909,23910,25118,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2850756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>St. Georgiev, V</contributor><creatorcontrib>BRAMMER, KEITH W.</creatorcontrib><creatorcontrib>FECZKO, JOSEPH M.</creatorcontrib><title>Single-Dose Oral Fluconazole in the Treatment of Vaginal Candidosis</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Early studies in patients demonstrated the potential of fluconazole, as a single oral 150-mg dose, for the treatment of vaginal candidosis. Fluconazole concentrations in plasma following this dose exceed the minimum inhibitory concentration (MIC) for most strains of Candida albicans (0.4-0.8 mg/l) for 3-4 days. This paper presents the results of two multicenter clinical studies in which the efficacy of this fluconazole dosage was compared with 1) intravaginal clotrimazole (200 mg, in a standard local treatment for 3 consecutive days) and 2) oral ketoconazole (200 mg, twice a day for 5 consecutive days) in the treatment of patients with acute vaginal candidosis.</description><subject>Administration, Oral</subject><subject>Administration, Topical</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Candidiasis, Vulvovaginal - drug therapy</subject><subject>Clinical Trials as Topic</subject><subject>Double-Blind Method</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Fluconazole</subject><subject>Humans</subject><subject>Ketoconazole - therapeutic use</subject><subject>Triazoles - administration &amp; dosage</subject><subject>Triazoles - therapeutic use</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM1Kw0AURgdRtFYfQQgu3CXOTOYvbkSrVqG2YKviapgkNzo1TTSTYvXpTWjoVpzFncX33XPhIHRMcECadzoPiGSRL0RIAxIpFdQxw4zTYLWFeptoG_UwltJXEQ330L5zc4wJVUzuol2qOJZc9NBgaovXHPyr0oE3qUzu3eTLpCzMT5mDZwuvfgNvVoGpF1DUXpl5T-bVFk1vYIrUpqWz7gDtZCZ3cNj9ffR4cz0b3PqjyfBucDHyk5Az4icZzWhMYhWB4jFNQxASC8ElbQYXzMQJxDRRRpJEElApZZhLExJlRMYEDfvoZM39qMrPJbhaL6xLIM9NAeXSaakExRGO_iyS5qakEWuKZ-tiUpXOVZDpj8ouTPWtCdataj3XrU_d-tStat2p1qtm-ai7sowXkG5WO7dNfr7Ov2wO3_8g6_HLxZQL0hD8NcG6GlYbgqnetZCh5Pp5PNSXYkTvFX7QPPwFufCcLA</recordid><startdate>1988</startdate><enddate>1988</enddate><creator>BRAMMER, KEITH W.</creator><creator>FECZKO, JOSEPH M.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>1988</creationdate><title>Single-Dose Oral Fluconazole in the Treatment of Vaginal Candidosis</title><author>BRAMMER, KEITH W. ; FECZKO, JOSEPH M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3541-cf2f2b1b89e85b2d3e67066572665564abceb2c8a71c71e8d24057a318a6f4623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Administration, Oral</topic><topic>Administration, Topical</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Candidiasis, Vulvovaginal - drug therapy</topic><topic>Clinical Trials as Topic</topic><topic>Double-Blind Method</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Fluconazole</topic><topic>Humans</topic><topic>Ketoconazole - therapeutic use</topic><topic>Triazoles - administration &amp; dosage</topic><topic>Triazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BRAMMER, KEITH W.</creatorcontrib><creatorcontrib>FECZKO, JOSEPH M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BRAMMER, KEITH W.</au><au>FECZKO, JOSEPH M.</au><au>St. Georgiev, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single-Dose Oral Fluconazole in the Treatment of Vaginal Candidosis</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>1988</date><risdate>1988</risdate><volume>544</volume><issue>1</issue><spage>561</spage><epage>563</epage><pages>561-563</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Early studies in patients demonstrated the potential of fluconazole, as a single oral 150-mg dose, for the treatment of vaginal candidosis. Fluconazole concentrations in plasma following this dose exceed the minimum inhibitory concentration (MIC) for most strains of Candida albicans (0.4-0.8 mg/l) for 3-4 days. This paper presents the results of two multicenter clinical studies in which the efficacy of this fluconazole dosage was compared with 1) intravaginal clotrimazole (200 mg, in a standard local treatment for 3 consecutive days) and 2) oral ketoconazole (200 mg, twice a day for 5 consecutive days) in the treatment of patients with acute vaginal candidosis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2850756</pmid><doi>10.1111/j.1749-6632.1988.tb40452.x</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0077-8923
ispartof Annals of the New York Academy of Sciences, 1988, Vol.544 (1), p.561-563
issn 0077-8923
1749-6632
language eng
recordid cdi_proquest_miscellaneous_78620909
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Administration, Oral
Administration, Topical
Antifungal Agents - therapeutic use
Candidiasis, Vulvovaginal - drug therapy
Clinical Trials as Topic
Double-Blind Method
Drug Administration Schedule
Female
Fluconazole
Humans
Ketoconazole - therapeutic use
Triazoles - administration & dosage
Triazoles - therapeutic use
title Single-Dose Oral Fluconazole in the Treatment of Vaginal Candidosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A36%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single-Dose%20Oral%20Fluconazole%20in%20the%20Treatment%20of%20Vaginal%20Candidosis&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=BRAMMER,%20KEITH%20W.&rft.date=1988&rft.volume=544&rft.issue=1&rft.spage=561&rft.epage=563&rft.pages=561-563&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/j.1749-6632.1988.tb40452.x&rft_dat=%3Cproquest_cross%3E15727294%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15727294&rft_id=info:pmid/2850756&rfr_iscdi=true